STOCK TITAN

Karen M. Anderson sells ADRs; CNTA (NASDAQ: CNTA) Form 144 notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CNTA filed a Form 144 reporting proposed sales of American Depositary Receipts (ADRs). The notice lists an ADR sale tied to an exercise of stock options for cash with an action date of 03/17/2026. The filing also discloses prior disposals by Karen M. Anderson on 03/13/2026 of 120,029 ADRs for $3,150,680.17 and on 03/16/2026 of 64,768 ADRs for $1,826,969.27.

Positive

  • None.

Negative

  • None.

Insights

Form 144 records planned ADR dispositions by an insider following option exercise.

The filing lists an ADR sale linked to an exercise of stock options for 03/17/2026, indicating a disposition event rather than a routine grant. The excerpt names Karen M. Anderson and shows two prior reported sales of ADRs on 03/13/2026 and 03/16/2026 with specific share counts and proceeds.

Cash‑flow treatment is explicit as cash for the 03/17/2026 entry. Subsequent SEC reports or Form 4/5 filings may provide additional attribution and ownership detail.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CNTA's Form 144 report?

It reports a proposed sale of ADRs tied to an exercise of stock options dated 03/17/2026. The notice also lists prior ADR disposals by Karen M. Anderson on 03/13/2026 and 03/16/2026, with share counts and proceeds.

How many ADRs did Karen M. Anderson sell recently for CNTA?

The excerpt shows sales of 120,029 ADRs on 03/13/2026 and 64,768 ADRs on 03/16/2026. The filing ties a separate ADR sale to an option exercise dated 03/17/2026 in the same sequence of transactions.

What proceeds were reported for the recent CNTA ADR sales?

The filing lists proceeds of $3,150,680.17 for the 120,029 ADRs sale on 03/13/2026 and $1,826,969.27 for the 64,768 ADRs sale on 03/16/2026. The 03/17/2026 exercise entry shows cash as the consideration.

Does the Form 144 indicate how the 03/17/2026 ADRs will be sold?

The excerpt identifies the 03/17/2026 entry as an Exercise of Stock Options with consideration listed as cash. The filing does not provide additional distribution methods in the provided excerpt.

Is the 03/17/2026 ADR transaction an acquisition or a disposition for CNTA insiders?

The 03/17/2026 line is recorded under 'Securities To Be Sold' and is linked to an exercise of stock options, indicating the filing reports a planned or proposed disposition rather than an acquisition.
Centessa Pharmaceuticals Plc

NASDAQ:CNTA

View CNTA Stock Overview

CNTA Rankings

CNTA Latest News

CNTA Latest SEC Filings

CNTA Stock Data

4.19B
134.77M
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
ALTRINCHAM, CHESHIRE